Eli Lilly and Company
Lucas Montarce (EVP & CFO) reports LLY insider transactions
AI-generated summary
EVP & CFO Lucas Montarce acquired 1,610 shares of Common Stock from RSU vesting for no reported cost on November 1, 2026. On the same date, 677.593 shares of Common Stock were disposed of for tax withholding at an average price of $1,417.54, valued at $960,515.18. Following these transactions, Lucas Montarce directly held 17,190.88 shares of Common Stock.
Key facts
- Insider
- Lucas Montarce · EVP & CFO
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 1, 2026 | M · exercise or conversion of a derivative | +1,610 | $0.00 | $0.00 | 17,868.473 | Direct |
| Nov 1, 2026 | F · tax withholding | −677.593 | $1,417.54 | $960,515.18 | 17,190.88 | Direct |
| Nov 1, 2026 | M · exercise or conversion of a derivativeRestricted Stock UnitFootnotes F1 | −1,610 | $0.00 | $0.00 | 0 | Direct |
Footnotes
- F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More LLY filings
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.